Menu

• Ask a Health Expert about GRANULOCYTES ABNORMAL
• Post Your Side Effect related to GRANULOCYTES ABNORMAL
• GRANULOCYTES ABNORMAL and FDA Warnings
• GRANULOCYTES ABNORMAL in Patients Wiki
• Report GRANULOCYTES ABNORMAL in Drug Side Effect Survey

GRANULOCYTES ABNORMAL side effect

What is GRANULOCYTES ABNORMAL ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Taxotere Side Effects Report #5720039-3
Health Professional from UNITED STATES reported TAXOTERE problem on Apr 16, 2008. Male patient, 74 years of age, weighting 141.1 lb, was diagnosed with prostate cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: granulocytes abnormal, hypocalcaemia, hypophosphataemia, mucosal inflammation, neutrophil count abnormal, stomatitis, . TAXOTERE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, PREDNISONE. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5371016-6
GLEEVEC problem was reported by a Physician from UNITED STATES on Mar 07, 2007. Female patient, 47 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: granulocytes abnormal, macrocytosis, mean cell volume abnormal, megakaryocytes abnormal, myelodysplastic syndrome, . GLEEVEC dosage: 400 MG, QD, ORAL. Patient recovered.

Velcade Side Effects Report #5584899-1
Physician from UNITED STATES reported VELCADE problem on Dec 19, 2007. Male patient, 62 years of age, weighting 165.3 lb, was diagnosed with squamous cell carcinoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, granulocytes abnormal, hypocalcaemia, orthostatic hypotension, white blood cell disorder, . VELCADE dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Vincristine Side Effects Report #5608515-5
VINCRISTINE problem was reported by a Physician from GERMANY on Jan 16, 2008. Male patient, 56 years of age, was diagnosed with b-cell lymphoma stage iv, b-lymphocyte count increased and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, granulocytes abnormal, haematopoietic stem cell mobilisation, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN. Patient recovered.


Tazocilline Side Effects Report #5361480-0
Health Professional from FRANCE reported TAZOCILLINE problem on June 14, 2007. Female patient, 68 years of age, was treated with TAZOCILLINE. After drug was administered, patient experienced the following problems/side effects: bone marrow toxicity, granulocytes abnormal, megakaryocytes abnormal, pancytopenia, pyrexia, respiratory distress, . TAZOCILLINE dosage: unknown. During the same period patient was treated with MOTILIUM, TRIFLUCAN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Nicardipine Side Effects Report #5297426-3
NICARDIPINE HYDROCHLORIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 26, 2007. Female patient, 65 years of age, was treated with NICARDIPINE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: bone marrow myelogram abnormal, granulocytes abnormal, histiocytosis haematophagic, leukopenia, multiple injuries, neutropenia, pneumothorax, . NICARDIPINE HYDROCHLORIDE dosage: unknown. During the same period patient was treated with ACUPAN, LORAZEPAM, VENLAFAXINE, ESOMEPRAZOLE, ACETAMINOPHEN. Patient recovered.

Erlotinib Side Effects Report #5782718-1
Health Professional from UNITED STATES reported ERLOTINIB problem on June 04, 2008. Female patient, weighting 280.0 lb, was diagnosed with lung adenocarcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, granulocytes abnormal, neutrophil count decreased, platelet count decreased, . ERLOTINIB dosage: (150 MG, QD), ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.